The PACIRA Trial is a multi-center, randomized, study to evaluate the safety, efficacy and pharmacokinetics of a single injection femoral nerve block with liposome bupivacaine for postoperative pain for patients undergoing a total knee replacement.
The Clinical Trails Program at Northern Westchester Hospital is actively recruiting for this trial. Enrollment will end in October.
More Articles on Clinical Trials:
MUMC Participates in Trial of Facet Joint Replacement as Spinal Stenosis Treatment
Medtronic to Recruit 323 Patients for Back Pain Treatment Clinical Trial
FDA Approves Ampion Biologic Clinical Trial
